RENAL TOXICITY OF PEMETREXED IN PATIENTS WITH NON-SMALL-CELL LUNG CANCER

被引：0
|
作者：
Inoue, Y. [1 ]
Karayama, M. [1 ]
Ito, Y. [1 ]
Kusagaya, H. [1 ]
Matsuura, S. [1 ]
Nakamura, Y. [1 ]
Inui, N. [1 ]
Suda, T. [1 ]
机构：
[1] Hamamatsu Univ, Dept Internal Med, Sch Med, Div 2, Hamamatsu, Shizuoka, Japan
来源：
ANNALS OF ONCOLOGY | 2013年 / 24卷
关键词：
D O I：
10.1093/annonc/mdt460.16
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：81 / 81
页数：1
相关论文
共 50 条
  • [1] The place of pemetrexed in the management of non-small-cell lung cancer patients
    Tomasini, Pascale
    Greillier, Laurent
    Khobta, Nataliya
    Barlesi, Fabrice
    EXPERT REVIEW OF ANTICANCER THERAPY, 2013, 13 (03) : 257 - 266
  • [2] Pemetrexed in the treatment of non-small-cell lung cancer
    Cash, R.
    Dangoor, A.
    LUNG CANCER, 2015, 87 : S27 - S27
  • [3] Pemetrexed in advanced non-small-cell lung cancer
    Fuld, Alexander D.
    Dragnev, Konstantin H.
    Rigas, James R.
    EXPERT OPINION ON PHARMACOTHERAPY, 2010, 11 (08) : 1387 - 1402
  • [4] Pemetrexed for the treatment of non-small-cell lung cancer
    Manegold, Christian
    Schmid-Bindert, Gerald
    Pilz, Lothar R.
    EXPERT REVIEW OF ANTICANCER THERAPY, 2009, 9 (09) : 1195 - 1209
  • [5] Effect of liver toxicity on clinical outcome of patients with non-small-cell lung cancer treated with pemetrexed
    Sakamori, Yuichi
    Kim, Young Hak
    Yoshida, Hironori
    Nakaoku, Takashi
    Nagai, Hiroki
    Yagi, Yoshitaka
    Ozasa, Hiroaki
    Mishima, Michiaki
    MOLECULAR AND CLINICAL ONCOLOGY, 2015, 3 (02) : 334 - 340
  • [6] PEMETREXED IN PREVIOUSLY TREATED NON-SMALL-CELL LUNG CANCER
    Cho, E.
    Hong, J.
    Kim, Y. S.
    Sim, S. J.
    Park, S. H.
    Park, J.
    Lee, J. H.
    Shin, D. B.
    ANNALS OF ONCOLOGY, 2008, 19 : 120 - 120
  • [7] Non-small-cell lung cancer - maintenance treatment with pemetrexed
    Krzakowski, Maciej
    ONCOLOGY IN CLINICAL PRACTICE, 2013, 9 (02): : 55 - 59
  • [8] LIVER TOXICITY AS A PREDICTIVE FACTOR FOR SURVIVAL IN PATIENTS WITH NON-SMALL-CELL LUNG CANCER TREATED WITH PEMETREXED.
    Sakamori, Yuichi
    Kim, Young Hak
    Nagai, Hiroki
    Yoshida, Hironori
    Nakaoku, Takashi
    Yagi, Yoshio
    Mishima, Michiaki
    JOURNAL OF THORACIC ONCOLOGY, 2012, 7 (11) : S485 - S486
  • [9] Genetic polymorphism in ATIC is associated with effectiveness and toxicity of pemetrexed in non-small-cell lung cancer
    Visser, Sabine
    Koolen, Stijn
    van Donk, Nadine
    van Walree, Nico
    van der Leest, Cor
    Cornelissen, Robin
    van Schaik, Ron
    Mathijssen, Ron
    Aerts, Joachim
    Stricker, Bruno H.
    THORAX, 2021, 76 (11) : 1150 - 1153
  • [10] Renal Toxicity in Patients with Non-Small Cell Lung Cancer Receiving Maintenance Therapy with Pemetrexed and Pembrolizuma
    Weber, U. M.
    Nicklawsky, A. G.
    Yoder, B. A.
    Schenk, E. L.
    Bunn, P. A.
    Camidge, D. R.
    Patil, T.
    JOURNAL OF THORACIC ONCOLOGY, 2024, 19 (10) : S249 - S249
12345